Synagis and Epilepsy aggravated - a phase IV clinical study of FDA data

Summary:

Epilepsy aggravated is reported as a side effect among people who take Synagis (palivizumab), especially for people who are female, 0-1 old, have been taking the drug for < 1 month also take Levetiracetam, and have Premature baby.

The phase IV clinical study analyzes which people have Epilepsy aggravated when taking Synagis. It is created by eHealthMe based on reports of 19,108 people who have side effects when taking Synagis from the FDA, and is updated regularly.

What is Synagis?

Synagis has active ingredients of palivizumab. eHealthMe is studying from 19,114 Synagis users. Check the latest studies of Synagis.

What is Epilepsy aggravated?

Epilepsy aggravated (serious common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,068 drugs and 456 conditions by eHealthMe. Check the latest studies of Epilepsy aggravated.

On Jul, 07, 2026

19,108 people reported to have side effects when taking Synagis.
Among them, 60 people (0.31%) have Epilepsy aggravated.

Could Synagis cause Epilepsy aggravated?

Among these 60 people:

How long have people been on Synagis when they have Epilepsy aggravated? *

What is the gender of people who have Epilepsy aggravated when taking Synagis? *

female: 51.67 %
male: 48.33 %

What is the age of people who have Epilepsy aggravated when taking Synagis? *

What are other drugs people take besides Synagis? *

What are other side effects people have besides Epilepsy aggravated? *

Infantile Spasms: 14 people, 23.33%
Respiratory Tract Infection: 11 people, 18.33%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 16.67%
Fever: 9 people, 15.00%
Hypophagia (reduced food intake): 8 people, 13.33%
Muscle Spasms (muscle contraction): 6 people, 10.00%
Apnea (temporary absence or cessation of breathing): 5 people, 8.33%
Nausea And Vomiting: 5 people, 8.33%
Device Related Infection: 5 people, 8.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 5.00%

What are the existing conditions these people have? *

Premature Baby: 15 people, 25.00%
Bronchopulmonary Dysplasia (chronic lung disorder in infants - enlargement of an organ or tissue by the proliferation of cells of an abnormal type): 3 people, 5.00%
Neonatal Aspiration (aspiration by neonate): 2 people, 3.33%
Canavan Disease (degenerative disorder that causes progressive damage to nerve cells in the brain): 2 people, 3.33%
Tracheomalacia (a structural abnormality of the tracheal (windpipe) cartilage resulting in the collapse of the wall of the trachea which obstructs the airway): 1 person, 1.67%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 1 person, 1.67%
Muscle Spasms (muscle contraction): 1 person, 1.67%
Lung Disorder (lung disease): 1 person, 1.67%
Chronic Respiratory Disease: 1 person, 1.67%
Bronchostenosis (narrowing of a bronchial tube by scarring or other stricture): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Synagis and have Epilepsy aggravated?

- Check whether Epilepsy aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Synagis:

Synagis (19,114 reports)

Browse all side effects of Synagis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy aggravated:

Epilepsy aggravated (1,068 drugs)

Browse all the conditions that are associated with Epilepsy aggravated:

Epilepsy aggravated (456 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on palivizumab (the active ingredients of Synagis) and Synagis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.